Skye Bioscience Surpasses 50 percent Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor

SKYE Stock  USD 2.85  0.02  0.71%   
About 54% of Skye Bioscience,'s investor base is interested to short. The analysis of the overall investor sentiment regarding Skye Bioscience, Common suggests that many traders are impartial. The current market sentiment, together with Skye Bioscience,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Skye Bioscience, Common stock news signals to limit their universe of possible portfolio assets.
  
SAN DIEGO, Nov. 14, 2024 -- Skye Bioscience, Inc. , a clinical-stage biopharmaceutical company focused on...

Read at globenewswire.com
Macroaxis News: globenewswire.com
  

Skye Bioscience, Fundamental Analysis

We analyze Skye Bioscience,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Skye Bioscience, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Skye Bioscience, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

100%
Skye Bioscience, is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Skye Bioscience, Common Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Skye Bioscience, stock to make a market-neutral strategy. Peer analysis of Skye Bioscience, could also be used in its relative valuation, which is a method of valuing Skye Bioscience, by comparing valuation metrics with similar companies.

Peers

Skye Bioscience, Related Equities

PASGPassage Bio   45.61   
0%
100.0%
VXRTVaxart   16.67   
0%
36.0%
ALECAlector   8.99   
0%
19.0%
JAGXJaguar Animal   5.50   
0%
12.0%
LRMRLarimar Therapeutics   4.24   
0%
9.0%
SILOSilo Pharma   4.21   
0%
9.0%
CABACabaletta Bio   3.00   
0%
6.0%
BDTXBlack Diamond   2.80   
0%
6.0%
STOKStoke Therapeutics   1.95   
0%
4.0%
GLUEMonte Rosa   0.84   
0%
1.0%
RVMDRevolution Medicines   0.27   
0%
1.0%
TNXPTonix Pharmaceuticals   6.06   
13.0%
0%

Complementary Tools for Skye Stock analysis

When running Skye Bioscience,'s price analysis, check to measure Skye Bioscience,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skye Bioscience, is operating at the current time. Most of Skye Bioscience,'s value examination focuses on studying past and present price action to predict the probability of Skye Bioscience,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skye Bioscience,'s price. Additionally, you may evaluate how the addition of Skye Bioscience, to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEOs Directory
Screen CEOs from public companies around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device